| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/31/2006 | CN1778823A Homogeneous tremella polysaccharide modifier with multiple biological activity, its production and preparation containing them |
| 05/31/2006 | CN1778820A Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 05/31/2006 | CN1778819A Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 05/31/2006 | CN1778373A Health-care composition |
| 05/31/2006 | CN1778359A Medicated wine for treating functional uterus bleeding |
| 05/31/2006 | CN1778356A Rehabilitation powder for paralysis |
| 05/31/2006 | CN1778312A High-exudation anabiotic liquid, its preparation and use thereof |
| 05/31/2006 | CN1778306A Use of pennogenin in preparing medicines for enhance of hemopoietic function |
| 05/31/2006 | CN1778305A Use of Pennogenin in preparing hemostatic medicines |
| 05/31/2006 | CN1778295A Medical use for silybum or its salt |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257748C Preparation and preparing method for asthenia diseases of breath and blood circulation systems |
| 05/31/2006 | CN1257720C Capsule of Chinese traditional medicine for treating thrombus |
| 05/31/2006 | CN1257719C Application of cnidium oil in preparing medicine for treating cerebral thrombus and headache |
| 05/31/2006 | CN1257713C Flunarizine hydrochloride injection and its preparing method |
| 05/31/2006 | CN1257711C Butyl benzene phthalein soft capsule and its preparation method |
| 05/31/2006 | CN1257710C Preparation made from effective position of red sage root, and its preparation method |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053047 Cyclic pentapeptides and their preparation |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052700 Treating gynecological blood stasis, cardio-cerebral vascular diseases, respiratory system and urinary system diseases |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/26/2006 | WO2006055412A1 Methods of treating erythropoietin-resistance |
| 05/26/2006 | WO2006055103A1 Oxygenated albumin for use as blood and blood extender |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006054624A1 Adhesion preventive and method of preventing adhesion |
| 05/26/2006 | WO2006054298A2 Glycogen synthase kinase-3 inhibitors |
| 05/26/2006 | WO2006053390A1 A method of modulating b cell functioning |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2005118551A3 Thrombopoietin activity modulating compounds and methods |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2587732A1 Glycogen synthase kinase-3 inhibitors |
| 05/26/2006 | CA2587558A1 Methods of treating erythropoietin-resistance |
| 05/26/2006 | CA2587407A1 A method of modulating b cell functioning |
| 05/26/2006 | CA2585502A1 Adhesion preventive and method of preventing adhesion |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111553 Novel thrombin inhibitors, the preparation and use thereof |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111433 Administering bergapten; modulate the expression of genes for gamma-globin in the human cell line K562; genetic blood disorders |
| 05/25/2006 | US20060111418 Blood-brain barrier disruption inhibitor |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111282 for treatment of blood coaggulation disorders; trauma |
| 05/25/2006 | US20060110473 Composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 05/25/2006 | US20060110425 Leech extracts for stents |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110372 Regulatory cells that control T cell immunoreactivity |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659115A1 Synthesis of substituted 2H-indazole derivatives as anti-angiogenic agents |
| 05/24/2006 | EP1658074A1 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1409705B1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | DE10128266B4 Verfahren zur Herstellung eines Extrakts aus Zingiber officinale A process for preparing an extract of Zingiber officinale |
| 05/24/2006 | CN1777416A Lactate containing pharmaceutical composition and uses thereof |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775776A Ligustrazine alkyl piperazine derivative, and its preparing method and medicinal composition and use |
| 05/24/2006 | CN1775762A Liyustrazine acyl piperazine derivative, and its preparing method and medicinal composition and use |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775285A Use of glucoprotein for pharmaceuticals |
| 05/24/2006 | CN1775284A Blood-viscosity reducing agent |
| 05/24/2006 | CN1775267A Kaikoujian extract, Its preparing method and use |
| 05/24/2006 | CN1775234A Method for preparing compound Folium pyrrosial particles and its quality control technology |
| 05/24/2006 | CN1775226A Use of attenuated salmonella carraying human PF4 gene for chemotherapeutic protection and hematopoietic reconstitution |
| 05/24/2006 | CN1775219A Medicinal formulation for preventing and treating ischemic vascular disease, and its preparing method and use |
| 05/24/2006 | CN1257158C N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity |
| 05/24/2006 | CN1256983C Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049414 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049345 Fat-binding polymers |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049289 Labelled glutamine and lysine analogues |
| 05/23/2006 | US7049124 Hyaluronidase from the Hirudinaria manillensis isolation, purification and recombinant method of production |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7048954 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/23/2006 | CA2312729C Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease |
| 05/18/2006 | WO2006052718A2 Farnesyltransferase inhibitors for treating sepsis |
| 05/18/2006 | WO2006051937A1 Five-membered heterocyclic derivatives |